CIK: 0001595851 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Apr 9, 2020
Total Value: $525M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 200,000 | $64.37M | 12.3% | $321.86 | — | — | Put | 78462F103 |
| XBI | SPDR SERIES TRUST | 500,000 | $47.56M | 9.1% | $95.11 | — | — | Put | 78464A870 |
| ASND | ASCENDIS PHARMA A S | 200,000 | $27.82M | 5.3% | $139.12 | $106.36 | — | SPONSORED ADR | 04351P101 |
| — | CONSTELLATION PHARMCETICLS I | 575,500 | $27.11M | 5.2% | $47.11 | $47.11 | — | COM | 210373106 |
| AXSM | AXSOME THERAPEUTICS INC | 200,000 | $20.67M | 3.9% | $103.36 * | $16.12 | +150.6% | COM | 05464T104 |
| — | MIRATI THERAPEUTICS INC | 150,000 | $19.33M | 3.7% | $128.86 | $71.66 | — | COM | 60468T105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 650,000 | $17.99M | 3.4% | $27.68 * | $19.38 | +17.3% | COM | 462260100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 700,000 | $15.93M | 3.0% | $22.76 * | $15.79 | +5.8% | COM | 77313F106 |
| — | REATA PHARMACEUTICALS INC | 75,000 | $15.33M | 2.9% | $204.43 | $121.68 | — | CL A | 75615P103 |
| — | AERIE PHARMACEUTICALS INC | 575,000 | $13.9M | 2.6% | $24.17 | $22.23 | — | COM | 00771V108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,175,000 | $13.54M | 2.6% | $11.52 | $5.45 | — | COM | 00773U108 |
| IMVT | IMMUNOVANT INC | 800,000 | $12.7M | 2.4% | $15.87 * | $11.17 | 0.0% | COM | 45258J102 |
| FOLD | AMICUS THERAPEUTICS INC | 1,250,000 | $12.18M | 2.3% | $9.74 * | $11.59 | -21.0% | COM | 03152W109 |
| AUPH | AURINIA PHARMACEUTICALS INC | 600,000 | $12.16M | 2.3% | $20.26 * | $9.21 | 0.0% | COM | 05156V102 |
| — | BLUEPRINT MEDICINES CORP | 150,000 | $12.02M | 2.3% | $80.11 | $85.19 | — | COM | 09627Y109 |
| — | SAGE THERAPEUTICS INC | 150,000 | $10.83M | 2.1% | $72.19 | $145.19 | — | Call | 78667J108 |
| — | IMMUNOMEDICS INC | 500,000 | $10.58M | 2.0% | $21.16 | $9.20 | — | COM | 452907108 |
| BCRX | BIOCRYST PHARMACEUTICALS | 3,000,000 | $10.35M | 2.0% | $3.45 * | $4.34 | -42.0% | COM | 09058V103 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 350,000 | $9.688M | 1.8% | $27.68 * | $19.38 | +17.3% | Call | 462260100 |
| ARVN | ARVINAS INC | 225,000 | $9.245M | 1.8% | $41.09 * | $19.57 | +49.6% | COM | 04335A105 |
| APLS | APELLIS PHARMACEUTICALS INC | 300,000 | $9.186M | 1.7% | $30.62 * | $27.68 | 0.0% | Put | 03753U106 |
| SRPT | SAREPTA THERAPEUTICS INC | 65,000 | $8.388M | 1.6% | $129.05 * | $121.54 | -17.0% | COM | 803607100 |
| — | DBV TECHNOLOGIES S A | 750,000 | $8.025M | 1.5% | $10.70 | $10.70 | — | SPONSORED ADR | 23306J101 |
| — | MOMENTA PHARMACEUTICALS INC | 400,000 | $7.892M | 1.5% | $19.73 | $13.20 | — | COM | 60877T100 |
| CHRS | COHERUS BIOSCIENCES INC | 430,000 | $7.742M | 1.5% | $18.00 * | $18.44 | 0.0% | COM | 19249H103 |
| APLS | APELLIS PHARMACEUTICALS INC | 250,000 | $7.655M | 1.5% | $30.62 * | $27.68 | 0.0% | Call | 03753U106 |
| KALV | KALVISTA PHARMACEUTICALS INC | 415,000 | $7.391M | 1.4% | $17.81 * | $15.74 | -17.1% | COM | 483497103 |
| — | MYOVANT SCIENCES LTD | 450,000 | $6.984M | 1.3% | $15.52 | $15.52 | — | COM | G637AM102 |
| — | IVERIC BIO INC | 750,000 | $6.435M | 1.2% | $8.58 | $8.58 | — | COM | 46583P102 |
| — | ARQULE INC | 300,000 | $5.988M | 1.1% | $19.96 | $19.96 | — | COM | 04269E107 |
| FATE | FATE THERAPEUTICS INC | 275,000 | $5.382M | 1.0% | $19.57 * | $19.17 | -17.2% | COM | 31189P102 |
| — | AMARIN CORP PLC | 250,000 | $5.36M | 1.0% | $21.44 | — | — | Call | 023111206 |
| APLS | APELLIS PHARMACEUTICALS INC | 175,000 | $5.359M | 1.0% | $30.62 * | $27.68 | 0.0% | COM | 03753U106 |
| VRAYQ | VIEWRAY INC | 1,200,000 | $5.064M | 1.0% | $4.22 * | $5.75 | -43.8% | COM | 92672L107 |
| FXF | INVESCO CURNCYSHS SWISS FRAN | 52,000 | $4.949M | 0.9% | $95.17 | $94.60 | — | SWISS FRANC | 46138R108 |
| INSM | INSMED INC | 200,000 | $4.776M | 0.9% | $23.88 * | $20.34 | 0.0% | COM PAR $.01 | 457669307 |
| — | MERSANA THERAPEUTICS INC | 800,000 | $4.584M | 0.9% | $5.73 | $5.73 | — | COM | 59045L106 |
| — | KINIKSA PHARMACEUTICALS LTD | 350,000 | $3.871M | 0.7% | $11.06 | $11.06 | — | COM CL A | G5269C101 |
| MIST | MILESTONE PHARMACEUTICALS IN | 235,000 | $3.762M | 0.7% | $16.01 * | $20.62 | -13.8% | COM | 59935V107 |
| — | ORCHARD THERAPEUTICS PLC | 224,359 | $3.085M | 0.6% | $13.75 | $15.73 | — | ADS | 68570P101 |
| — | PHASEBIO PHARMACEUTICALS INC | 450,000 | $2.75M | 0.5% | $6.11 | $6.11 | — | COM | 717224109 |
| — | SELECTA BIOSCIENCES INC | 1,150,000 | $2.737M | 0.5% | $2.38 | $2.38 | — | COM | 816212104 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 33,400 | $2.655M | 0.5% | $79.49 | $79.49 | — | COM | 37890U108 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 40,000 | $2.178M | 0.4% | $54.45 | $42.31 | — | COM | G11196105 |
| — | CHIASMA INC | 425,000 | $2.108M | 0.4% | $4.96 | $5.18 | — | COM | 16706W102 |
| — | KADMON HLDGS INC | 462,500 | $2.095M | 0.4% | $4.53 | $3.79 | — | COM | 48283N106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 275,000 | $1.939M | 0.4% | $7.05 * | $9.61 | +3.3% | COM | 74366E102 |
| FXB | INVESCO CURNCYSHS BRIT PND S | 11,600 | $1.49M | 0.3% | $128.45 | $119.25 | — | BRIT POUN STRL | 46138M109 |
| — | KARYOPHARM THERAPEUTICS INC | 50,500 | $968K | 0.2% | $19.17 | $19.17 | — | COM | 48576U106 |
| TGTX | TG THERAPEUTICS INC | 63,000 | $699K | 0.1% | $11.10 * | $7.60 | 0.0% | COM | 88322Q108 |
| ANAB | ANAPTYSBIO INC | 11,500 | $187K | 0.0% | $16.26 * | $23.65 | 0.0% | COM | 032724106 |
| — | SPECTRUM PHARMACEUTICALS INC | 38,340 | $140K | 0.0% | $3.65 | $3.65 | — | COM | 84763A108 |